comparemela.com

Page 18 - நுகர்வோர் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

TELUS Health first in Canada to provide residents with innovative LivingWell Companion personal emergency response services on Apple Watch Professionally-monitored, emergency service now available for the first time in Canada on a modern, powerful device, ensuring safety and providing peace of mind for Canadians and their caregivers

Article content VANCOUVER, British-Columbia, May 25, 2021 (GLOBE NEWSWIRE) TELUS Health, the largest Canadian-owned provider of personal emergency response services (PERS), today announced it is revolutionizing how Canadians experience wearable emergency support in Canada by launching TELUS Health Companion on Apple Watch. A 24/7 emergency monitoring service provided through TELUS Health’s LivingWell Companion national response service combined with the Apple Watch Fall Detection API and proactive monitoring functionalities, this new service enables more Canadians with health issues or who may be at risk of falling to experience improved safety and peace of mind. TELUS Health is helping advance innovation in the PERs industry by making it accessible through the modern and powerful intelligence of Apple Watch, while offering greater independence and a sense of security to those who want to live independently for longer.

Johnson & Johnson Limited appoints Charmaine England as Area Managing Director for Consumer Health Northern Europe

Search jobs Johnson & Johnson Limited appoints Charmaine England as Area Managing Director for Consumer Health Northern Europe Johnson & Johnson Limited is pleased to announce the appointment of Charmaine England as Area Managing Director for Consumer Health Northern Europe, effective 17 May 2021.  England will oversee the Northern Europe business, which includes the UK, Ireland, Norway, Sweden, Denmark and Finland. She will manage a portfolio of iconic Johnson & Johnson Consumer Health brands, including AVEENO®, JOHNSON’S®, LISTERINE®, NEUTROGENA®, OGX®, CALPOL® and NICORETTE®. In her new role, England joins the company’s Europe, Middle East and Africa (EMEA) Consumer Health Leadership team, where she will focus on meeting fast-evolving consumer needs, deepening partnerships with customers, and building an empowered team.

Johnson & Johnson appoints Charmaine England as area managing director for consumer health Northern Europe

Published on Johnson & Johnson Limited is pleased to announce the appointment of Charmaine England as area managing director for consumer health Northern Europe, effective 17 May 2021.  England will oversee the Northern Europe business, which includes the UK, Ireland, Norway, Sweden, Denmark and Finland. She will manage a portfolio of iconic Johnson & Johnson Consumer Health brands, including AVEENO®, JOHNSON’S®, LISTERINE®, NEUTROGENA®, OGX®, CALPOL® and NICORETTE®. In her new role, England joins the company’s Europe, Middle East and Africa (EMEA) Consumer Health Leadership team, where she will focus on meeting fast-evolving consumer needs, deepening partnerships with customers, and building an empowered team.

RCEP Media & Think Tank Forum - Chinadaily com cn

Introduction Officials, ambassadors, media veterans and scholars attend the forum to share their thoughts on how the Regional Comprehensive Economic Partnership agreement will propel regional cooperation in Asia. The event is jointly organized by the publicity department of the Hainan provincial government, China Daily, the China Institute for Reform and Development, and Institute for Free Trade Port with Chinese Characteristics. All Port business environment gets a new facelift As the RCEP trade agreement is planned to go into force next year, the General Administration of Customs has been working on a slew of measures, in a move to build up a market-oriented, legalized and internationalized port business environment, said Dang Yingjie, deputy director-general of the National Office of Port Administration.

JJ Presents on Skin Health, Oncology Care, Emotions/Acne and Sunscreens at AAD

The virtual meeting was held on April 23-25, 2021, where J&J featured a total of 13 posters and three oral presentations, including: Presentation #26630: The Role of Skin Barrier in Cutaneous Adverse Drug Reactions in Oncology Therapy and the Benefit of Topical Emollients; Presentation #26634: Insights into the Mechanisms of EGFRi-induced Cutaneous Adverse Drug Reactions From Functional Phospho-proteomic and Transcriptomic Data; and Presentation #27031: Sunscreens Designed and Validated by Consumers to be Invisible on All Skin Tones. Sun protection including sunscreen is vital for everyone to protect their skin from sun damage and help prevent skin cancer,” said Barbara Green, senior director of skin health translational science at J&J. “However, a common misconception is that Black and Brown communities do not benefit from sunscreen. We formulated products specifically to be invisible on the skin while feeling weightless and breathable. She added J&J was pleased to prese

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.